Arrestin Beta 1 (ARRB1) Antibody

ARRB1 Antibody is a Rabbit Polyclonal antibody against ARRB1. Members of ARRB1/beta-ARRB1 protein family are thought to participate in agonist-mediated desensitization of G-protein-coupled receptors and cause specific dampening of cellular responses to stimuli such as hormones, neurotransmitters, or sensory signals. ARRB1 is a cytosolic protein and acts as a cofactor in the beta-adrenergic receptor kinase (BARK) mediated desensitization of beta-adrenergic receptors. Besides the central nervous system, it is expressed at high levels in peripheral blood leukocytes, and thus the BARK/beta-ARRB1 system is believed to play a major role in regulating receptor-mediated immune functions. Alternatively spliced transcripts encoding different isoforms of ARRB1 have been described.

Target	Arrestin Beta 1 (ARRB1)
Clonality	Polyclonal
Reactivity	Human, Mouse, Rat
Tested Applications	WB, IHC, IF/ICC, IP
Host	Rabbit
Recommended dilutions	WB: 1/500 - 1/1000, IHC-P: 1/50 - 1/200, IF/ICC: 1/50 - 1/200, IP: 0.5-4 µg/200-400 µg whole cell extracts. Not tested in IHC-F. Optimal dilutions/concentrations should be determined by the end user.
Conjugation	Unconjugated
Immunogen	Recombinant fusion protein containing a sequence corresponding to amino acids 169-418 of human β-arrestin1.
Isotype	IgG
Form	Liquid
Purification	Purified by affinity chromatography.
Storage	Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
UniProt Primary AC	P49407 (UniProt, ExPASy)
UniProt Secondary AC	B6V9G8, O75625, O75630, Q2PP20, Q9BTK8
UniProt Entry Name	ARRB1_HUMAN
Gene Symbol	ARRB1
GeneID	408
NCBI Accession	NP_004032.2
KEGG	hsa:408
String	9606.ENSP00000409581
Molecular Weight	Calculated MW: 47 kDa Observed MW: 51 kDa
Buffer	PBS, pH 7.3, containing 0.01% thimerosal, 50% glycerol.
Concentration	> 0.2 mg/ml
Availability	Shipped within 5-10 working days.
Note	This product is for research use only.

Research Articles on Arrestin Beta 1 (ARRB1)

Write a review

Your Name

Your Email Address

PMID

DOI

Your Review

Rating

Continue